1. Home
  2. BWAY vs BBNX Comparison

BWAY vs BBNX Comparison

Compare BWAY & BBNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BrainsWay Ltd.

BWAY

BrainsWay Ltd.

HOLD

Current Price

$16.49

Market Cap

450.8M

Sector

Health Care

ML Signal

HOLD

Logo Beta Bionics Inc.

BBNX

Beta Bionics Inc.

HOLD

Current Price

$11.39

Market Cap

493.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BWAY
BBNX
Founded
2003
2015
Country
Israel
United States
Employees
N/A
423
Industry
Medical/Dental Instruments
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
450.8M
493.1M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
BWAY
BBNX
Price
$16.49
$11.39
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
10
Target Price
$13.25
$23.80
AVG Volume (30 Days)
144.8K
1.2M
Earning Date
05-12-2026
04-21-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$309.69
$34.90
Revenue Next Year
$26.21
$34.63
P/E Ratio
$81.98
N/A
Revenue Growth
N/A
N/A
52 Week Low
$8.59
$8.80
52 Week High
$26.63
$32.71

Technical Indicators

Market Signals
Indicator
BWAY
BBNX
Relative Strength Index (RSI) 59.22 48.95
Support Level $14.56 $11.33
Resistance Level $16.63 $11.92
Average True Range (ATR) 0.71 1.12
MACD 0.41 0.17
Stochastic Oscillator 95.83 56.26

Price Performance

Historical Comparison
BWAY
BBNX

About BWAY BrainsWay Ltd.

BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.

About BBNX Beta Bionics Inc.

Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company's product includes the iLet Bionic Pancreas (iLet). The company operates as a single segment, focused on the development, manufacture, and sale of the iLet.

Share on Social Networks: